EUVIMEDEUVIMED entdecken
Zurückgezogene PublikationOpen Access · CC BY 3.0

Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt , pfmdr1 , and pfdhfr Genes

Innocent M Ali, Palmer M Netongo, Barbara Atogho-Tiedeu, Eric-Olivier Ngongang, Anthony Ajua, Eric A Achidi, Wilfred F Mbacham

Malaria Research and Treatment · 2013

DOI: 10.1155/2013/234683 ↗

Kurz gefasst

Zurückgezogene Publikation in der Zeitschrift Malaria Research and Treatment, 2013. Verfasst von Innocent M Ali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Public Health Research Biotechnologies, University of Yaounde, BP 8094, Yaounde, Centre Region, Cameroon ; Department of Biochemistry,…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Ministry of Public Health, Cameroon.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In Cameroon, both Artesunate-amodiaquine (AS/AQ) and artemether-lumefantrine (AL) are used as first-line treatment against uncomplicated malaria in line with the WHO recommendations. We compared the efficacy and safety of both therapeutic combinations and determined the prevalence of drug resistance conferring mutations in three parasite genes.

Methods

One hundred and fifty acute malaria patients between six months and 14 years of age were randomized to receive standard doses of either AS/AQ (73) or AL (77) and followedup for 28 days. Outcome of treatment was according to the standard WHO classification. DNA samples from pretreatment parasite isolates were used to determine the prevalence of resistant mutations in the pfcrt , pfmdr1 , and dhfr genes.

Results

Both drug combinations induced rapid clearance of parasites and malaria symptoms. PCR-corrected cure rates were 100% and 96.4% for AL. The combinations were well tolerated. Major haplotypes included CVIET (71%), CVMNT (25%) for the pfcrt ; SND (100%) for the pfmdr1 ; IRN (79, 8%), NCS (8.8%), and mixed haplotype (11, 8%) for the dhfr .

Conclusion

Both AS/AQ and AL were highly effective and well tolerated for the treatment of uncomplicated falciparum malaria in Ngaoundere, Cameroon. High prevalence of mutant pfcrt alleles confirms earlier observations. Long-term monitoring of safety and efficacy and molecular markers is highly solicited.

Autor:innen und Institutionen

  • Laboratory for Public Health Research Biotechnologies, University of Yaounde, BP 8094, Yaounde, Centre Region, Cameroon ; Department of Biochemistry, University of Dschang, BP 67, Dschang, West Region, Cameroon.
  • Laboratory for Public Health Research Biotechnologies, University of Yaounde, BP 8094, Yaounde, Centre Region, Cameroon.
  • Laboratory for Public Health Research Biotechnologies, University of Yaounde, BP 8094, Yaounde, Centre Region, Cameroon ; Universite des Montagnes, BP 208, Bangante, West Region, Cameroon.
  • Laboratory for Public Health Research Biotechnologies, University of Yaounde, BP 8094, Yaounde, Centre Region, Cameroon ; Faculty of Science, University of Buea, BP 63, Buea, South West Region, Cameroon.
  • Faculty of Science, University of Buea, BP 63, Buea, South West Region, Cameroon.

Förderung

  • Ministry of Public Health, Cameroon

Zitieren

APA

Ali, I. M., Netongo, P. M., Atogho-Tiedeu, B., Ngongang, E. O., Ajua, A., Achidi, E. A., & Mbacham, W. F. (2013). Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt , pfmdr1 , and pfdhfr Genes. Malaria Research and Treatment. https://doi.org/10.1155/2013/234683

Vancouver

Ali IM, Netongo PM, Atogho-Tiedeu B, Ngongang EO, Ajua A, Achidi EA, et al. Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt , pfmdr1 , and pfdhfr Genes. Malaria Research and Treatment. 2013. doi:10.1155/2013/234683

BibTeX
@article{Ali2013,
  author = {Ali, Innocent M and Netongo, Palmer M and Atogho-Tiedeu, Barbara and Ngongang, Eric-Olivier and Ajua, Anthony and Achidi, Eric A and Mbacham, Wilfred F},
  title = {Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt , pfmdr1 , and pfdhfr Genes},
  journal = {Malaria Research and Treatment},
  year = {2013},
  doi = {10.1155/2013/234683}
}
Kostenlos starten →